Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

001065.KS


Top 10 Correlated ETFs

001065.KS


Top 10 Correlated Stocks

001065.KS


Financial details

Company Rating
Strong Buy
Market Cap
815.91B
Income
8.93B
Revenue
639.81B
Book val./share
1947.82
Cash/share
662.59
Dividend
350
Dividend %
1.04%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
-
P/E
395.3
Forward P/E
-
PEG
-28.39
P/S
5.52
P/B
17.22
P/C
50.63
P/FCF
94.91
Quick Ratio
0.29
Current Ratio
1.52
Debt / Equity
0.74
LT Debt / Equity
0.79
-
-
EPS (TTM)
245.81
EPS next Y
-
EPS next Q
-
EPS this Y
-98.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.28%
Revenue last 5Y
3.82%
Revenue Q/Q
5.54%
EPS Q/Q
-89.75%
-
-
-
-
SMA20
-6.53%
SMA50
-6.43%
SMA100
-10.47%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
4%
ROC
0.11%
Gross Margin
39%
Oper. Margin
7%
Profit Margin
1%
Payout
412%
Shs Outstand
20.1M
Shs Float
11.51M
-
-
-
-
Target Price
-
52W Range
27475.729-39000.0
52W High
-13.97%
52W Low
+22.11%
RSI
39.39
Rel Volume
0.13
Avg Volume
252
Volume
34
Perf Week
-4.55%
Perf Month
-8.08%
Perf Quarter
-12.52%
Perf Half Y
-11.24%
-
-
-
-
Beta
0.229318
-
-
Volatility
1160.88%, 1285.14%
Prev Close
3.55%
Price
33550
Change
3.55%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
20.68K22.09K21.03K22.51K5.78K
Net income per share
-30.53331.3-1.04K-626.72-9.23
Operating cash flow per share
1.38K2.14K2.28K2.59K172.78
Free cash flow per share
925.171.8K1.74K1.97K49.79
Cash per share
1.32K1.27K1.72K2.27K625.99
Book value per share
11.13K10.7K9.46K8.53K1.92K
Tangible book value per share
10.31K10.07K8.58K7.8K1.59K
Share holders equity per share
11.13K10.7K9.46K8.53K1.92K
Interest debt per share
8.19K7.56K8.17K7.8K2.41K
Market cap
589.93B589.12B617.78B819.29B3514.12B
Enterprise value
748.19B733.39B763.44B991.06B3725.89B
P/E ratio
-794.5573.12-24.44-53.75-3.63K
Price to sales ratio
1.171.11.211.55.79
POCF ratio
17.6411.3111.1212.99193.89
PFCF ratio
26.2213.4614.5617.06672.89
P/B Ratio
2.182.262.693.9517.47
PTB ratio
2.182.262.693.9517.47
EV to sales
1.491.371.491.816.14
Enterprise value over EBITDA
28.4320.04-281.9565.6183.81
EV to operating cash flow
22.3714.0713.7515.72205.58
EV to free cash flow
33.2516.7617.9920.64713.45
Earnings yield
00.01-0.04-0.020
Free cash flow yield
0.040.070.070.060
Debt to equity
0.050.180.140.360.61
Debt to assets
0.570.560.60.620.7
Net debt to EBITDA
6.013.94-53.811.374.76
Current ratio
1.51.641.211.281.3
Interest coverage
2.452.48-1.69-0.174.25
Income quality
-45.056.47-2.2-4.14-18.73
Dividend Yield
0.010.010.010.010
Payout ratio
-7.930.81-0.27-0.46-7.39
Sales general and administrative to revenue
0.120.120.080.120.14
Research and developement to revenue
0.040.040.050.040.03
Intangibles to total assets
0.030.030.040.030.03
Capex to operating cash flow
-0.33-0.16-0.24-0.24-0.71
Capex to revenue
-0.02-0.02-0.03-0.03-0.02
Capex to depreciation
-0.58-0.47-0.64-0.73-0.8
Stock based compensation to revenue
00000
Graham number
2.77K8.93K14.87K10.97K631
ROIC
0.060.06-0.0600.09
Return on tangible assets
00.01-0.05-0.030
Graham Net
-11.3K-10.36K-10.53K-9.69K-3.12K
Working capital
136.83B145.54B57.07B64.58B83.77B
Tangible asset value
250.64B244.97B208.7B189.8B167.07B
Net current asset value
51.27B40.23B-8.06B-42.29B-78.06B
Invested capital
0.70.670.820.881.22
Average receivables
00000
Average payables
53.74B46.17B46.49B47.89B49.76B
Average inventory
103.91B101.28B95.82B101.2B101.86B
Days sales outstanding
00000
Days payables outstanding
69.247.7146.9947.2650.64
Days of inventory on hand
123.83108.7894.2699.88100.54
Receivables turnover
00000
Payables turnover
5.277.657.777.727.21
Inventory turnover
2.953.363.873.653.63
ROE
00.03-0.11-0.070
Capex per share
-450.3-343.15-538.52-618.41-122.99

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
6K6.13K1.61K1.49K1.57K
Net income per share
-138.32209.32-63.9391.099.34
Operating cash flow per share
0.15927.64124.5854.8987.58
Free cash flow per share
-96.6794.8684.6518.866.33
Cash per share
2.34K2.85K624.11659.84662.59
Book value per share
8.26K8.49K1.91K1.93K1.95K
Tangible book value per share
7.49K7.73K1.59K1.62K1.63K
Share holders equity per share
8.26K8.49K1.91K1.93K1.95K
Interest debt per share
9.06K8.86K2.36K2.42K2.34K
Market cap
1227.76B759.09B3577.34B3982.43B3824.6B
Enterprise value
1436.82B945.61B3789.12B4201.06B4033.7B
P/E ratio
-91.2537.28-132.95103.88973.45
Price to sales ratio
8.415.0921.1125.4723.18
POCF ratio
336.88K33.65272.92689.53415.05
PFCF ratio
-522.6539.27401.652.01K548.02
P/B Ratio
6.113.6817.7819.5818.66
PTB ratio
6.113.6817.7819.5818.66
EV to sales
9.846.3522.3626.8724.45
Enterprise value over EBITDA
272.2474.68243.7235.62296.19
EV to operating cash flow
394.24K41.92289.08727.39437.74
EV to free cash flow
-611.6448.92425.432.12K577.98
Earnings yield
00.01000
Free cash flow yield
00.03000
Debt to equity
0.50.490.610.750.74
Debt to assets
0.660.650.70.70.69
Net debt to EBITDA
39.6114.7313.6212.2615.35
Current ratio
1.391.431.31.461.52
Interest coverage
1.474.574.435.643.39
Income quality
04.43-1.950.69.38
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.120.160.140.14
Research and developement to revenue
0.030.040.030.040.04
Intangibles to total assets
0.030.030.030.030.03
Capex to operating cash flow
-645.56-0.14-0.32-0.66-0.24
Capex to revenue
-0.02-0.02-0.02-0.02-0.01
Capex to depreciation
-0.59-0.81-1.04-0.81-0.56
Stock based compensation to revenue
00000
Graham number
5.07K6.32K1.66K1.99K639.63
ROIC
0.010.020.030.030.02
Return on tangible assets
-0.010.01-0.010.020
Graham Net
-11.19K-10.74K-3.11K-3.06K-2.92K
Working capital
95.65B105.57B83.77B117.4B124.64B
Tangible asset value
182.17B187.89B167.07B170.23B171.8B
Net current asset value
-40.02B-32B-78.06B-74.59B-68.51B
Invested capital
1.091.041.221.241.19
Average receivables
00000
Average payables
51.15B52.68B53B54.36B56.49B
Average inventory
107.79B108.54B104.81B107.1B109.29B
Days sales outstanding
00000
Days payables outstanding
47.7548.4444.7353.1452.84
Days of inventory on hand
108.05104.4588.8104.7100.51
Receivables turnover
00000
Payables turnover
1.881.862.011.691.7
Inventory turnover
0.830.861.010.860.9
ROE
-0.020.02-0.030.050
Capex per share
-96.75-132.77-39.93-36.09-21.25

Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a US stock and trading under the symbol 001065.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $33550 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap